Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES
Document Type and Number:
WIPO Patent Application WO/2011/096642
Kind Code:
A3
Abstract:
The present invention relates to a pharmaceutical composition for preventing and treating inflammatory diseases, containing 2-[2-chloro-6-(3-iodobenzyl)-furyn-9-yl]-tetrahydro-thiophene-3,4-diol (LJ-1888) or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition according to the present invention has a remarkably low toxicity compared with a known A3 adenosine receptor agonist or antagonist, and is thus useful for preventing and treating inflammatory diseases.

Inventors:
JEONG LAK SHIN (KR)
LEE SANG KOOK (KR)
CHUNG HWA JIN (KR)
LEE HYUK WOO (KR)
Application Number:
PCT/KR2010/009112
Publication Date:
November 10, 2011
Filing Date:
December 20, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV EWHA IND COLLABORATION (KR)
JEONG LAK SHIN (KR)
LEE SANG KOOK (KR)
CHUNG HWA JIN (KR)
LEE HYUK WOO (KR)
International Classes:
A61K31/52; A61K31/4178; A61P19/02; A61P29/00
Domestic Patent References:
WO2008108508A12008-09-12
WO2008023362A22008-02-28
Other References:
BOZAROV, ANDREY ET AL.: "Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine", AMERICAN JOURNAL OF PHYSIOLOGY - GASTROINTESTINAL AND LIVER PHYSIOLOGY, vol. 297, 2009, pages G1147 - G1162
MABLEY, JON ET AL.: "The adenosine A3 receptor agonist, N6-(3-iodobenzyl)- adenosine-5'-N-methyluronamide, is protective in two murine models of colitis", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 466, no. 3, 2003, pages 323 - 329
Attorney, Agent or Firm:
KIM, Yoon-bae (8th Floor Dongduk Building,151-8, Kwanhoon-dong, Jungro-gu, Seoul 110-300, KR)
Download PDF:
Claims:



 
Previous Patent: REGENERATOR

Next Patent: PHOTOCHROMIC MATERIAL